Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
2,020
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosis

Juan Carlos Olivares-Gazcaa Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México;b Universidad Popular Autónoma del Estado de Puebla, Puebla, México
,
Robert Peter Galec Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK
,
Daniela Sánchez-Bonillaa Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México;b Universidad Popular Autónoma del Estado de Puebla, Puebla, México
,
Moisés Manuel Gallardo-Péreza Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México;b Universidad Popular Autónoma del Estado de Puebla, Puebla, México
,
Silvia Soto-Olverab Universidad Popular Autónoma del Estado de Puebla, Puebla, México;d Laboratorios Ruiz, Clínica Ruiz, Puebla, México
,
Guillermo J. Ruiz-Delgadoa Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México;b Universidad Popular Autónoma del Estado de Puebla, Puebla, México;d Laboratorios Ruiz, Clínica Ruiz, Puebla, MéxicoCorrespondence[email protected]
&
Guillermo José Ruiz-Argüellesa Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, México;b Universidad Popular Autónoma del Estado de Puebla, Puebla, MéxicoORCID Iconhttps://orcid.org/0000-0002-9335-0653
ORCID Icon show all
Article: 2164443 | Received 26 Sep 2022, Accepted 29 Dec 2022, Published online: 10 Jan 2023

References

  • Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory immune response and COVID-19: a double edged sword. Front Immunol. 2021 Sep 30;12:742941. DOI:10.3389/fimmu.2021.742941. PMID: 34659238; PMCID: PMC8515020.
  • Revannasiddaiah S, Kumar Devadas S, Palassery R, et al. A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2. Med Hypotheses. 2020 Nov;144:109850. DOI:10.1016/j.mehy.2020.109850. Epub 2020 May 23. PMID: 32526511; PMCID: PMC7244432.
  • Bołtuć K, Bielejewska A, Coloma-Millar A, et al. Case report: cyclophosphamide in COVID-19 – when an absolute contraindication is an absolute necessity. F1000Research. 2021 Aug 19;10:829. DOI:10.12688/f1000research.55625.1. PMID: 34646504; PMCID: PMC8436184.
  • Olivares Gazca JC, Gómez Almaguer D, Gale RP, et al. Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis. Hematology. 2020 Dec;25(1):320. DOI:10.1080/16078454.2020.1802931. PMID: 32783598.
  • Murrieta-Álvarez I, Cantero-Fortiz Y, León-Peña AA, et al. The 1,000th transplant for multiple sclerosis and other autoimmune disorders at the HSCT-México program: a myriad of experiences and knowledge. Front Neurol. 2021 Feb 22;12:647425. DOI:10.3389/fneur.2021.647425. PMID: 33692748; PMCID: PMC7937693.
  • Zabalza A, Cárdenas-Robledo S, Tagliani P, et al. COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response. Eur J Neurol. 2021 Oct;28(10):3384–3395. DOI:10.1111/ene.14690. Epub 2021 Jan 9. PMID: 33340215.
  • Colunga-Pedraza PR, Colunga-Pedraza JE, Meléndez-Flores JD, et al. Outpatient transplantation in the COVID-19 era: a single-center Latin American experience. Bone Marrow Transplant. 2021 Sep;56(9):2287–2290. DOI:10.1038/s41409-021-01360-4. Epub 2021 May 27. PMID: 34045692; PMCID: PMC8155174.
  • Langer-Gould A, Smith JB, Li BH. Multiple sclerosis, rituximab, and COVID-19. Ann Clin Transl Neurol. 2021 Apr;8(4):938–943. DOI:10.1002/acn3.51342. Epub 2021 Mar 30. PMID: 33783140; PMCID: PMC8045943.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.